Wasabi (Eutrema japonicum)
Wasabi (Eutrema japonicum) is a Japanese cruciferous plant whose primary bioactive compounds, isothiocyanates such as 6-methylsulfinylhexyl isothiocyanate (6-MSITC), are released upon enzymatic breakdown of glucosinolates by myrosinase. These isothiocyanates have been investigated for potential antioxidant, anti-inflammatory, and antimicrobial properties, though human clinical evidence remains extremely limited.
Origin & History
Wasabi (Eutrema japonicum) is a perennial plant native to mountain streams in Japan, Korea, and eastern Russia, now cultivated worldwide primarily for its rhizomes used as a pungent condiment. The plant belongs to the Brassicaceae family, with key compounds derived from roots, leaves, stems, and rhizomes containing glucosinolates that hydrolyze to yield volatile isothiocyanates.
Historical & Cultural Context
Eutrema japonicum has been used historically in Japanese, Korean, and Russian cuisines as a condiment from its rhizomes for its pungent flavor. The plant has been recognized as medicinal due to its isothiocyanate content, though specific traditional medicine systems or durations are not detailed in available sources.
Health Benefits
• No human clinical trials were identified in the research provided • Chemical analysis shows presence of isothiocyanates which have been studied in other contexts • Contains glucosinolates found in other cruciferous vegetables • Research focuses on chemical composition and plant growth rather than health effects • Evidence quality: No clinical evidence available
How It Works
When wasabi tissue is disrupted, the enzyme myrosinase hydrolyzes glucosinolates into isothiocyanates, particularly 6-methylsulfinylhexyl isothiocyanate (6-MSITC). These isothiocyanates can activate the Nrf2/Keap1 pathway, upregulating antioxidant response elements and phase II detoxification enzymes such as glutathione S-transferase and NAD(P)H quinone oxidoreductase 1. Additionally, 6-MSITC has been shown in preclinical models to inhibit NF-κB signaling, thereby reducing pro-inflammatory cytokine production including TNF-α and IL-6.
Scientific Research
No human clinical trials, randomized controlled trials (RCTs), or meta-analyses on Eutrema japonicum (wasabi) were identified in the provided sources. Research focuses on chemical composition, nematicidal activity, nutritional profiles, and plant growth, with no PubMed PMIDs for human studies reported.
Clinical Summary
No published randomized controlled trials or formal human clinical studies specifically evaluating wasabi supplements for health outcomes were identified in the available research. Existing evidence derives primarily from in vitro cell studies and animal models examining 6-MSITC and related isothiocyanates, which limits the ability to draw conclusions about efficacy, effective dosing, or safety in humans. Some observational interest exists around wasabi consumption in traditional Japanese dietary patterns, but these associations have not been isolated in controlled research. The overall evidence base is considered preliminary, and claims about therapeutic benefits cannot currently be substantiated by clinical data.
Nutritional Profile
Wasabi (Eutrema japonicum) rhizome contains approximately 69-74% water, with dry weight composition including: Carbohydrates ~56-60% of dry weight (primarily starch and soluble sugars), Protein ~15-18% of dry weight (notably higher than many root vegetables), Dietary fiber ~8-10% of dry weight, Fat ~1-3% of dry weight. Key micronutrients per 100g fresh weight: Potassium ~568mg, Calcium ~128mg, Vitamin C ~41mg, Magnesium ~69mg, Phosphorus ~80mg, Zinc ~1.6mg, Iron ~1.0mg, Sodium ~17mg. Primary bioactive compounds: Isothiocyanates (ITCs) — principally 6-methylsulfinylhexyl isothiocyanate (6-MSITC, also called wasabi) at approximately 0.45-1.2mg/g fresh rhizome, alongside allyl isothiocyanate (AITC) at lower concentrations (~0.1-0.3mg/g); these are hydrolysis products of glucosinolates activated by the enzyme myrosinase upon tissue disruption. Glucosinolates present include glucoerucin (~1.8-3.2µmol/g dry weight) and sinigrin (~0.8-1.5µmol/g dry weight). Additional phenolic compounds include hydroxycinnamic acid derivatives and flavonoids (quercetin, kaempferol glycosides) at ~0.3-0.8mg/g dry weight. Bioavailability notes: Isothiocyanate release is myrosinase-dependent and reduced significantly in processed or cooked forms; most commercial 'wasabi' products use horseradish substitute with lower 6-MSITC content; fresh grated rhizome provides highest bioavailable ITC concentration, though ITCs are volatile and degrade within 15-30 minutes of preparation.
Preparation & Dosage
No clinically studied dosage ranges for extracts, powder, or standardized forms of wasabi were identified, as human trials are absent from available research. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Other cruciferous vegetables, glucosinolate-containing plants, traditional Japanese herbs
Safety & Interactions
Wasabi consumed as a food condiment is generally regarded as safe for most adults, but concentrated supplements providing high-dose isothiocyanates have not been evaluated in formal human safety trials. High intake of isothiocyanates from cruciferous vegetables as a class may interfere with iodine uptake and thyroid function, suggesting caution for individuals with hypothyroidism or those taking thyroid medications such as levothyroxine. Wasabi may theoretically interact with anticoagulant drugs like warfarin due to potential effects on platelet aggregation observed in preclinical studies, though this has not been confirmed in humans. Pregnant and breastfeeding women should avoid supplemental doses beyond culinary amounts given the absence of safety data in these populations.